Thought Leadership
How To Build Strategic Readiness For First-In-Human Studies
Moving from IND submission to first patient enrollment requires more than regulatory […]
Read More....Charting the Path to First-in-Human Studies: Strategic Planning for Early Clinical Success
The transition to first-in-human studies is one of the most significant and […]
Read More....Avoid the Wrecking Ball: Targeted Solutions for Struggling Trials
When clinical trials begin to veer off course, the instinctive response is […]
Read More....Fixing the Monitoring Model: How a Flexible Resource Supports Trial Success
As clinical trials become more complex, traditional monitoring models are increasingly difficult […]
Read More....Founders Forward Focus Forum: Interview with Joe Arcangelo
If you want a real look into what drives InSeption Group’s culture, […]
Read More....Streamlining Clinical Data Management
In clinical development, data management should be a strategic advantage — not […]
Read More....Regulatory Submission Crisis Rescue
In today’s highly competitive development landscape, a regulatory submission can unravel quickly—and […]
Read More....Philadelphia Business Journal Thought Leadership: Life Sciences
We’re proud to share that Robin Johnson, PharmD, Gene Therapy Submissions Lead […]
Read More....5 Medical Writing Best Practices For Gene Therapy BLA/MAA Submissions
Gene therapy programs continue to push the boundaries of modern medicine — […]
Read More....Dispelling Common Clinical Trial Oversight Myths
Clinical trial oversight can be a tricky dynamic to navigate—especially for Sponsors. […]
Read More....